← Product Code [LKZ](/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/LKZ) · K832771

# ERYTHROCYTE TEST (K832771)

_Bio-Analytics Laboratories, Inc. · LKZ · Oct 28, 1983 · Hematology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/LKZ/K832771

## Device Facts

- **Applicant:** Bio-Analytics Laboratories, Inc.
- **Product Code:** [LKZ](/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/LKZ.md)
- **Decision Date:** Oct 28, 1983
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 864.7100
- **Device Class:** Class 2
- **Review Panel:** Hematology

## Regulatory Identification

Red blood cell enzyme assay is a device used to measure the activity in red blood cells of clinically important enzymatic reactions and their products, such as pyruvate kinase or 2,3-diphosphoglycerate. A red blood cell enzyme assay is used to determine the enzyme defects responsible for a patient's hereditary hemolytic anemia.

---

**Source:** [https://fda.innolitics.com/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/LKZ/K832771](https://fda.innolitics.com/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/LKZ/K832771)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com